Recruiting
Phase 2
Phase 3

LMN-201 for Prevention of C. Difficile Infection Recurrence

Sponsor:

Lumen Bioscience, Inc.

Code:

NCT05330182

Conditions

Clostridioides Difficile Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LMN-201

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Lumen Bioscience, Inc. on 2025-03-25.